Highbridge Capital Management’s IVERIC bio ISEE Stock Holding History
Bought
Maintained
Sold
Other funds holding ISEE
Highbridge Capital Management's ISEE Position: Q4 2016 in Review
Highbridge Capital Management sold out of IVERIC bio (ISEE) in Q4 2016, closing a stake of 4,925 shares — an estimated $227K sold.
Highbridge Capital Management first reported a position in ISEE in Q2 2014 and held it in 6 quarters. The position peaked at $6.45M in Q3 2015. 137 funds tracked by Wall St. Rank hold ISEE as of Q4 2016.
- Highbridge Capital Management reported no remaining IVERIC bio position as of Q4 2016 after selling out during the quarter.
- Highbridge Capital Management sold 4,925 IVERIC bio shares in Q4 2016, an estimated $227K.
- Highbridge Capital Management first reported a position in IVERIC bio in Q2 2014 and held it in 6 quarters.
- Highbridge Capital Management's IVERIC bio position peaked at $6.45M in Q3 2015.
- 137 funds tracked by Wall St. Rank held IVERIC bio as of Q4 2016.
Based on Highbridge Capital Management's 13F filing for Q4 2016, filed 14 Feb 2017.